Elrig has announced details of a microfluidics and nanotechnology conference, which is due to take place on 23 June 2010 at Astrazeneca's Alderley Park site in Manchester, UK.
The free conference, entitled 'Microfluidics and Nanotechnology in Drug Discovery', will look at developments in screening platforms, chemistries, ultra-high throughput and the sensitive detection of analytes.
Attendees will learn how these technologies will affect bio-sciences and drug discovery research.
They will also see how these technologies are being deployed in the drug discovery process.
